Ultrasound study probes diabetes Drug's effect on digestion
NCT ID NCT07313813
Summary
This study aims to understand how fasting and temporarily stopping the diabetes medication dulaglutide affect how much food and liquid stays in the stomach after a meal. Researchers will use ultrasound scans to measure stomach contents in about 20 adults with type 2 diabetes. The goal is to gather information to help guide safe fasting practices before medical procedures for people taking this type of medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Lilly Centre for Clinical Pharmacology
RECRUITINGSingapore, 138623, Singapore
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.